Antiandrogens reverse docetaxel resistance via ABCB1 inhibition

被引：2
|
作者：
Annette Fenner
机构：
来源：
Nature Reviews Urology | 2015年 / 12卷 / 7期
关键词：
D O I：
10.1038/nrurol.2015.135
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：361 / 361
相关论文
共 50 条
  • [21] Lapatinib potentiates cytotoxicity of  YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter
    Branka Radic-Sarikas
    Melinda Halasz
    Kilian V. M. Huber
    Georg E. Winter
    Kalliopi P. Tsafou
    Theodore Papamarkou
    Søren Brunak
    Walter Kolch
    Giulio Superti-Furga
    Scientific Reports, 7
  • [22] Polymorphisms of ABCB1 and CYP1B1 in prostate cancer patients treated with docetaxel
    Chioni, A.
    Giovannetti, E.
    Pastina, I.
    Lastella, M.
    Mey, V.
    Cianci, C.
    Nannizzi, S.
    Orlandini, C.
    Cacio, E.
    Danesi, R.
    Del Tacca, M.
    Ricci, S.
    ANNALS OF ONCOLOGY, 2005, 16 : 81 - 82
  • [23] Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function
    Dai, Chun-ling
    Liang, Yong-ju
    Chen, Li-ming
    Zhang, Xu
    Deng, Wen-jing
    Su, Xiao-dong
    Shi, Zhi
    Wu, Chung-pu
    Ashby, Charles R., Jr.
    Akiyama, Shin-ichi
    Ambudkar, Suresh V.
    Chen, Zhe-sheng
    Fu, Li-wu
    BIOCHEMICAL PHARMACOLOGY, 2009, 78 (04) : 355 - 364
  • [24] L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines
    Chiu, Ling-Yen
    Ko, Jiunn-Liang
    Lee, Yi-Ju
    Yang, Tsung-Ying
    Tee, Yi-Torng
    Sheu, Gwo-Tarng
    TOXICOLOGY LETTERS, 2010, 192 (03) : 408 - 418
  • [25] Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer
    Chen, Haiyang
    Shien, Kazuhiko
    Suzawa, Ken
    Tsukuda, Kazunori
    Tomida, Shuta
    Sato, Hiroki
    Torigoe, Hidejiro
    Watanabe, Mototsugu
    Namba, Kei
    Yamamoto, Hiromasa
    Soh, Junichi
    Asano, Hiroaki
    Miyoshi, Shinichiro
    Toyooka, Shinichi
    ONCOLOGY LETTERS, 2017, 14 (04) : 4349 - 4354
  • [26] Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma
    Susa, Michiro
    Iyer, Arun K.
    Ryu, Keinosuke
    Choy, Edwin
    Hornicek, Francis J.
    Mankin, Henry
    Milane, Lara
    Amiji, Mansoor M.
    Duan, Zhenfeng
    PLOS ONE, 2010, 5 (05):
  • [27] Cellular polarity modulates drug resistance in primary colorectal cancers via orientation of the multidrug resistance protein ABCB1
    Ashley, Neil
    Ouaret, Djamila
    Bodmer, Walter F.
    JOURNAL OF PATHOLOGY, 2019, 247 (03): : 293 - 304
  • [28] MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells
    Yang, Tao
    Zheng, Zhi-min
    Li, Xiao-na
    Li, Zhen-fu
    Wang, Yan
    Geng, Yun-feng
    Bai, Li
    Zhang, Xian-bo
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2013, 238 (09) : 1024 - 1032
  • [29] Genetics of ABCB1 in Cancer
    Skinner, Katie T.
    Palkar, Antara M.
    Hong, Andrew L.
    CANCERS, 2023, 15 (17)
  • [30] Inhibition of the transmembrane transporter ABCB1 overcomes resistance to doxorubicin in patient-derived organoid models of HCC
    Blukacz, Lauriane
    Nuciforo, Sandro
    Fucile, Geoffrey
    Trulsson, Fredrik
    Duthaler, Urs
    Wieland, Stefan
    Heim, Markus H.
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (05)
12345